Other highlights in the May 16 JNCI

Alcohol Drinking Linked to Reduced Risk of Renal Cell Cancer

Drinking moderate amounts of alcohol is associated with a decreased risk of renal cell cancer.

Some studies have found that people who drink alcohol have a lower risk of renal cell cancer, but these studies included a small number of patients.

Jung Eun Lee, Sc.D., of Brigham and Womens Hospital and Harvard Medical School in Boston, and colleagues analyzed 12 prospective studies of alcohol consumption among renal cell cancer patients.

In both men and women, drinking at least one alcoholic beverage a day, on average, was associated with a 30 percent reduced risk of renal cell cancer, compared with no alcohol intake. The type of alcoholic beverage did not appear to be important as lower risks were seen with beer, wine, and liquor.

"However, because alcohol drinking is associated with increased risks of cancers of the oral cavity, larynx, pharynx, esophagus, liver, and breast, and probably the colon and rectum, maintaining a healthy weight and avoiding smoking are the principal known means to reduce the risk of renal cell cancer that should be encouraged and doing so may also reduce the risk of many other cancers as well as cardiovascular disease," the authors write.

Contact: Jessica Podlaski, media relations coordinator, Brigham and Womens Hospital, (617) 534-1603, jpodlaski@partners.org

Childhood Leukemia and Lymphoma Survivors Have Elevated Risk of Second Cancers

Survivors of childhood leukemia and lymphoma, particularly Hodgkin lymphoma, are at a high risk for secondary cancers.

To quantify this risk, Milena Maule, Ph.D., of the University of Turin in Italy, and colleagues compared the rates of second cancers in survivors of childhood leukemia and lymphoma with the cancer rate in the general population. They used a very large dataset that inc

Contact: Liz Savage
Journal of the National Cancer Institute

Page: 1 2 3 4

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights from the June 6 JNCI
7. Other highlights from the April 18 Journal of the National Cancer Institute
8. Other highlights from the March 21 JNCI
9. Other highlights in the March 7 JNCI
10. Other highlights in the Feb. 21 JNCI
11. Other highlights in the Jan. 17 JNCI

Post Your Comments:

(Date:7/22/2020)... , ... July 21, 2020 , ... ... transformation and innovation in technology and compliance, announces a new solution to manage ... must ensure every layer of their technology stack complies with FDA and global ...
(Date:7/18/2020)... , ... July 17, 2020 , ... Commercial launch readiness ... pharma’s ability to discover a COVID cure or vaccine, the global economic downturn will ... price pressure is not going away and capturing full value from every product launch ...
(Date:7/10/2020)... CHICAGO (PRWEB) , ... July 09, 2020 , ... Today ... Umami Advantage, which will share insight on the “fifth taste” phenomenon that is revolutionizing ... snacks. The Umami Advantage will be live on Monday, July 13, 2020 at11:00 AM ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as ... cover the history of eSource, the reasons it did not take off as quickly ... site source, the industry is moving towards capturing data electronically for clinical trials and ...
(Date:7/22/2020)... , ... July 22, 2020 , ... Join experts from ... Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar on ... regulating body in China for drugs and medical devices. Specifically, for medical devices, the ...
(Date:7/18/2020)... , ... July 16, 2020 , ... ... to aid in the early detection and prevention of high-burden diseases, and Centric ... US-based hospitals and healthcare organizations to utilize existing data in order to identify ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Institute of Technology (MIT) has expanded the company’s exclusive license to include ... into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
Breaking Biology Technology:
Cached News: